Search bioRxiv⌕ Search

Biology subjects

Hawkes, C.

Publications and source records attributed to Hawkes, C..

2 recordsLinked to original sources

Niche constraints drive differences between mycorrhizal fungal guilds in future range shifts

Mycorrhizal fungi are a diverse and ubiquitous group of plant symbionts whose distribution strongly influences ecosystem function across the globe. Yet, until now, we do not have quantitative data on the range sizes of different mycorrhizal fungal taxa, limiting our capacity to forecast future shifts in community composition and function. Here, we use 115,924 DNA sequence-derived observations to map the distribution of 651 common mycorrhizal fungal taxa and forecast future changes to their range sizes. We demonstrate that climate, plant cover, and soil factors, particularly mean annual temperature, net primary productivity, and soil organic carbon, exert major control over mycorrhizal fungal distributions. Based on these drivers, the ecological niches of mycorrhizal fungi consistently differ between arbuscular and ectomycorrhizal functional guilds. Arbuscular mycorrhizal fungal taxa generally occupy a wider niche breadth than ectomycorrhizal fungi, occurring across larger ranges of climate, soil, plant cover, topography, and disturbance conditions. Our models also predict widespread decreases in the suitable range size of mycorrhizal fungal taxa under projected future global climates, with average ranges decreasing by 13.8% or ~2.2 million km2 under high emissions scenarios (ssp5-8.5). This decrease in projected range size will be most pronounced for ectomycorrhizal fungi, strongly linked to constraints from their smaller overall niches. By generating a global atlas of common mycorrhizal fungi and their associated environmental niche, we establish a critical baseline for widely suspected declines in global fungal biodiversity.

ecology↗

EHZ2 inhibition enhances the activity of platinum chemotherapy in aggressive variant prostate cancer

BackgroundEZH2 promotes aggressive-variant prostate cancer (AVPC) progression via histone H3-Lysine-27 tri-methylation (H3K27me3). We hypothesize that epigenetic reprogramming via EZH2 inhibitors (EZH2i) improves the efficacy of chemotherapy in AVPC. MethodsWe studied the expression of EZH2 in clinical prostate cancer cohorts (bioinformatics). We determined the effect of EZH2i on both cellular- and cell-free-H3K27me3 levels. We measured effects of carboplatin with/without EZH2i on AVPC cell viability (IC50). We studied how EZH2i modulate gene expression (RNA Seq). ResultsEZH2 was significantly up-regulated in AVPC vs other prostate cancer types. EZH2i reduced both cellular and cell free-H3K27me3 levels. EZH2i significantly reduced carboplatin IC50. EZH2i reduced the expression of DNA repair and increased the expression of pro-apoptotic genes. Article HighlightsO_LIPolycomb-mediated gene silencing promotes prostate cancer progression C_LIO_LIAggressive-variant prostate cancers (AVPCs) are characterized by increased activity of the Polycomb-Repressive Complex 2 (PRC2) C_LIO_LIHere we show that PRC2 inhibitors are scarcely effective as monotherapy in ACPC cells C_LIO_LIHowever the combination of PRC2 inhibitors and carboplatin is highly synergistic C_LIO_LIRNA Seq studies revealed that PRC2 inhibitors enhance carboplatin activity by modulating several key pathways, including DNA repair and apoptosis. C_LI

pharmacology and toxicology↗